BioMarin Pharmaceutical Inc. (BMRN)
Growth
Revenue 5Y8.70%
Revenue 3Y6.63%
EPS 5Y13.78%
EPS 3Y5.89%
Dividend 5Y-
Dividend 3Y-
Capital Efficiency
ROIC1.88%
ROE1.89%
ROA1.34%
ROTA1.42%
Capital Structure
Market Cap21.80B
EV22.12B
Cash761.51M
Current Ratio5.15
Debt/Equity0.27
Net Debt/EBITDA1.50
BMRN
Income Statement
Select a metric from the list below to chart it
Dec '98
Dec '03
Dec '08
Dec '13
Dec '18
Income Statement | Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 548.5 | 751.0 | 889.9 | 1,116.9 | 1,313.6 | 1,491.2 | 1,704.0 | 1,860.5 | 1,846.3 | 2,008.3 | |
Revenue % Chg. | 9.5% | 36.9% | 18.5% | 25.5% | 17.6% | 13.5% | 14.3% | 9.2% | -0.8% | 8.6% | |
Cost of Revenue | 95.7 | 129.8 | 152.0 | 209.6 | 241.8 | 315.3 | 359.5 | 524.3 | 470.5 | 476.1 | |
Cost of Revenue % Chg. | 4.3% | 35.5% | 17.1% | 37.9% | 15.3% | 30.4% | 14.0% | 45.8% | -10.3% | -0.2% | |
Gross Profit | 452.7 | 621.3 | 737.9 | 907.2 | 1,071.9 | 1,175.9 | 1,344.6 | 1,336.2 | 1,375.8 | 1,532.2 | |
Gross Profit % Chg. | 10.7% | 37.2% | 18.8% | 23.0% | 18.1% | 9.7% | 14.3% | -0.6% | 3.0% | 11.7% | |
Gross Profit Margin | 82.5% | 82.7% | 82.9% | 81.2% | 81.6% | 78.9% | 78.9% | 71.8% | 74.5% | 76.3% | |
Gross Profit Margin % Chg. | 1.1% | 0.2% | 0.2% | -2.0% | 0.4% | -3.4% | 0.1% | -9.0% | 3.8% | 2.8% | |
R&D Expenses | 354.8 | 461.5 | 634.8 | 661.9 | 610.8 | 696.3 | 715.0 | 628.1 | 628.8 | 637.9 | |
R&D Expenses % Chg. | 17.4% | 30.1% | 37.5% | 4.3% | -7.7% | 14.0% | 2.7% | -12.2% | 0.1% | 2.2% | |
Selling, General, & Admin Expenses | 235.4 | 302.2 | 402.3 | 476.6 | 554.3 | 604.4 | 680.9 | 737.7 | 759.4 | 825.8 | |
Selling, General, & Admin Expenses % Chg. | 18.8% | 28.4% | 33.1% | 18.5% | 16.3% | 9.0% | 12.7% | 8.3% | 2.9% | 12.0% | |
Other Expenses | 18.6 | 18.0 | -17.7 | -27.0 | 46.5 | 48.8 | 74.1 | 62.2 | 61.9 | 62.7 | |
Other Expenses % Chg. | -0.6% | -3.5% | - | 52.4% | - | 5.0% | 51.9% | -16.1% | -0.5% | 0.0% | |
Operating Income | -156.0 | -92.9 | -110.7 | -803.4 | -14.7 | -123.5 | -100.5 | -36.8 | -82.3 | 108.2 | |
Operating Income % Chg. | 41.5% | 40.5% | 19.2% | 625.8% | 98.2% | 740.3% | 18.7% | 63.4% | 124.0% | - | |
Operating Income Margin | -28.4% | -12.4% | -12.4% | -71.9% | -1.1% | -8.3% | -5.9% | -2.0% | -4.5% | 5.4% | |
Operating Income Margin % Chg. | 29.2% | 56.5% | 0.6% | 478.3% | 98.4% | 640.2% | 28.8% | 66.5% | 125.7% | - | |
Total Other Income/Expenses Net | -20.5 | -32.0 | -44.0 | -27.6 | -21.2 | -19.2 | 5.6 | -5.6 | 7.0 | -7.6 | |
Total Other Income/Expenses Net % Chg. | 154.2% | 56.0% | 37.7% | 37.3% | 23.3% | 9.4% | - | - | - | - | |
Income Before Tax | -176.5 | -124.9 | -154.7 | -831.1 | -35.9 | -142.7 | -94.8 | -42.3 | -75.4 | 100.6 | |
Income Before Tax % Chg. | 49.2% | 29.3% | 23.9% | 437.1% | 95.7% | 297.8% | 33.6% | 55.4% | 78.0% | - | |
Income Before Tax Margin | -32.2% | -16.6% | -17.4% | -74.4% | -2.7% | -9.6% | -5.6% | -2.3% | -4.1% | 5.0% | |
Income Before Tax Margin % Chg. | 36.2% | 48.3% | 4.6% | 328.0% | 96.3% | 250.4% | 41.9% | 59.1% | 79.4% | - | |
Income Tax Expense | -0.2 | 9.1 | 17.1 | -200.8 | 81.2 | -65.5 | -71.0 | -901.4 | -11.3 | 16.6 | |
Income Tax Expense % Chg. | 96.2% | - | 87.6% | - | - | - | 8.4% | 1170.3% | 98.7% | - | |
Net Income | -176.4 | -134.0 | -171.8 | -630.2 | -117.0 | -77.2 | -23.8 | 859.1 | -64.1 | 83.9 | |
Net Income % Chg. | 54.2% | 24.0% | 28.2% | 266.8% | 81.4% | 34.0% | 69.1% | - | - | 427.2% | |
Net Income Margin | -32.2% | -17.8% | -19.3% | -56.4% | -8.9% | -5.2% | -1.4% | 46.2% | -3.5% | 4.2% | |
Net Income Margin % Chg. | 40.8% | 44.5% | 8.2% | 192.3% | 84.2% | 41.9% | 73.0% | - | - | 385.3% | |
Weighted Avg. Shares Out | 137.8 | 146.3 | 160.0 | 166.0 | 174.4 | 177.1 | 179.0 | 180.8 | 180.8 | 184.6 | |
Weighted Avg. Shares Out % Chg. | 14.5% | 6.2% | 9.3% | 3.7% | 5.1% | 1.5% | 1.1% | 1.0% | - | 1.3% | |
EPS | -1.3 | -0.9 | -1.1 | -3.8 | -0.7 | -0.4 | -0.1 | 4.8 | -0.4 | 0.5 | |
EPS % Chg. | 34.7% | 28.1% | 16.3% | 255.1% | 82.4% | 34.3% | 70.5% | - | - | 400.0% | |
Weighted Avg. Shares Out Dil | 137.8 | 146.3 | 160.0 | 166.2 | 174.4 | 177.3 | 179.0 | 191.7 | 191.7 | 187.9 | |
Weighted Avg. Shares Out Dil % Chg. | 14.5% | 6.2% | 9.3% | 3.9% | 4.9% | 1.6% | 1.0% | 7.1% | - | 1.9% | |
EPS Diluted | -1.3 | -0.9 | -1.1 | -3.8 | -0.7 | -0.4 | -0.1 | 4.5 | -0.3 | 0.4 | |
EPS Diluted % Chg. | 34.7% | 28.1% | 16.3% | 256.1% | 82.4% | 34.3% | 70.5% | - | - | 425.0% | |
Interest Income | 3.1 | 5.9 | 4.5 | 7.5 | 14.9 | 22.8 | 22.7 | 16.6 | 10.5 | 11.1 | |
Interest Income % Chg. | 19.3% | 92.6% | -24.2% | 66.3% | 98.4% | 53.7% | -0.4% | -27.0% | -36.9% | -6.3% | |
Interest Expense | 10.4 | 33.3 | 35.0 | 36.1 | 39.0 | 40.1 | 21.4 | 29.3 | 14.7 | 15.6 | |
Interest Expense % Chg. | 36.8% | 218.8% | 4.9% | 3.4% | 7.9% | 2.7% | -46.5% | 36.8% | -49.7% | -3.1% | |
EBIT | -183.9 | -152.2 | -185.2 | -859.7 | -60.0 | -159.9 | -93.5 | -55.0 | -79.6 | 96.0 | |
EBIT % Chg. | 49.1% | 17.2% | 21.6% | 364.3% | 93.0% | 166.5% | 41.5% | 41.1% | 44.7% | - | |
EBIT Margin | -33.5% | -20.3% | -20.8% | -77.0% | -4.6% | -10.7% | -5.5% | -3.0% | -4.3% | 4.8% | |
EBIT Margin % Chg. | 36.1% | 39.5% | 2.7% | 269.9% | 94.1% | 134.8% | 48.8% | 46.1% | 45.8% | - | |
Depreciation & Amortization | 47.3 | 56.7 | 47.2 | 96.9 | 87.9 | 95.7 | 105.3 | 105.2 | 108.0 | 103.4 | |
Depreciation & Amortization % Chg. | 4.3% | 20.1% | -16.8% | 105.4% | -9.3% | 8.9% | 10.1% | -0.1% | 2.7% | -5.5% | |
EBITDA | -136.6 | -95.5 | -138.0 | -762.8 | 27.9 | -64.3 | 11.8 | 50.2 | 28.4 | 199.4 | |
EBITDA % Chg. | 75.0% | 30.1% | 44.5% | 452.8% | - | - | - | 324.7% | -43.3% | 255.1% | |
EBITDA Margin | -24.9% | -12.7% | -15.5% | -68.3% | 2.1% | -4.3% | 0.7% | 2.7% | 1.5% | 9.9% | |
EBITDA Margin % Chg. | 59.8% | 48.9% | 21.9% | 340.5% | - | - | - | 289.0% | -42.9% | 226.8% |